We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 13% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and medical device stocks a median 3%.
How the business stands, the timeline, and its peers, for Pro members.
| Long-term trend | −3 |
| Latest filing | 10-Q, Aug 6 |
ReportReports Thursday, before the open. Every 3 months, a company tells everyone how much it sold and earned. It rose after 2 and fell after 2 of its last 4 reports, +0.2% on average. Past reports ›
After its last 4 reports it closed +0.3% on average, higher 2 of 4 times.
ENOV is #58 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 58 |
Reports Thu Nov 5, before the open (in 2 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
ENOV's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“We are encouraged by this progress but acknowledge there is more work ahead to deliver consistent durable growth, particularly as we anticipate a more dynamic macroeconomic environment in the second half.”
From its results filing (SEC filing · Aug 6)
Sales grew 15% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 4.6% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 6, 2026 | -4.4% | -12.8% | -18.2% |
| May 7, 2026 | +1.2% | +9.7% | +3.4% |
| Feb 26, 2026 | +1.3% | +13.9% | +15.6% |
Sales grew in six of the last seven years, to $2.2B in 2025. It made a profit in three of the eight years.
2 insiders bought $542K across 9 filings in the last 6 months. No open-market sales on record. The newest:
2 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: ENOV is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
ENOV scores 1 today, which Breakaway calls Below Average. It is #58 of 85 in Medical Devices by Quality Score, with 3 of 14 chart checks firing. Down 13% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and medical device stocks a median 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
ENOV scores 1 today, which Breakaway calls Below Average (0 to 5). That is #58 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ENOV's 1.
2 insiders bought $542K across 9 filings in the last 6 months. No open-market sales on record. The newest is Oliver Engert, Chief Administrative Officer, who bought $50K on Sep 4. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.